Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 8Liver Neoplasms 5Carcinoma, Hepatocellular 4Lung Neoplasms 3Squamous Intraepithelial Lesions 2Prostatic Neoplasms 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Unresectable Pancreatic Cancer 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasm Metastasis 1Melanoma 1Lymphatic Metastasis 1Liver, Cancer of, Non-Resectable 1Laryngeal Neoplasms 1Hilus Pulmonary Neoplasms 1Head and Neck Neoplasms 1HIV Seropositivity 1Gallbladder Neoplasms 1Extremities Neoplasms 1Esophageal Neoplasms 1Colorectal Liver Metastases 1Carcinoma, Renal Cell 1

Interventions

Vincristine 1VGX-3100 1Tomography, X-Ray Computed 1Spirometry 1Rituximab 1Prednisone 1Etoposide 1Electroporation Therapies 1Electroporation 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × HIV Seropositivity × Electroporation × Clear all
NCT03603808 2026-05-08

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

AIDS Malignancy Consortium

Phase 2 Completed
44 enrolled 15 charts
Gynecologic

Squamous Intraepithelial Lesions, HIV Seropositivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡